Literature DB >> 3073147

Synthesis and disulfide structure determination of porcine endothelin: an endothelium-derived vasoconstricting peptide.

S Kumagaye1, H Kuroda, K Nakajima, T X Watanabe, T Kimura, T Masaki, S Sakakibara.   

Abstract

All disulfide analogs (types A, B and C) of porcine or human endothelin, a 21-amino acid peptide having two intramolecular disulfide bonds, were synthesized and their retention times on HPLC were compared with that of natural endothelin. One of the analogs (type A) having disulfide bonds between positions 1 and 15 and between 3 and 11 was found to be identical with natural endothelin. Random oxidation of fully reduced endothelin formed a mixture of type A and B in a ratio of 3:1, with almost none of type C, which has disulfide bonds between positions 1 and 3 and between 11 and 15. Type A endothelin was also synthesized by the segment condensation procedure in solution applying our maximum protection strategy. This product was found to have full vasoconstricting activity in rat pulmonary artery ring preparations; the potency was as high as that of the natural product.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3073147     DOI: 10.1111/j.1399-3011.1988.tb01383.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


  8 in total

Review 1.  Endothelin: a review of its effects and possible mechanisms of action.

Authors:  W Lovenberg; R C Miller
Journal:  Neurochem Res       Date:  1990-04       Impact factor: 3.996

2.  Role of the prosequence of guanylin.

Authors:  A Schulz; U C Marx; Y Hidaka; Y Shimonishi; P Rösch; W G Forssmann; K Adermann
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

3.  Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells.

Authors:  P Vigne; R Marsault; J P Breittmayer; C Frelin
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

4.  Disulfide structures of highly bridged peptides: a new strategy for analysis.

Authors:  W R Gray
Journal:  Protein Sci       Date:  1993-10       Impact factor: 6.725

5.  High-yield production of human big endothelin-1 by a combination of chemical modification and proteolysis of a fusion protein in Escherichia coli.

Authors:  H Ohashi; K Yasufuku; M Yano
Journal:  Appl Microbiol Biotechnol       Date:  1994-08       Impact factor: 4.813

6.  Two-step selective formation of three disulfide bridges in the synthesis of the C-terminal epidermal growth factor-like domain in human blood coagulation factor IX.

Authors:  Y Yang; W V Sweeney; K Schneider; B T Chait; J P Tam
Journal:  Protein Sci       Date:  1994-08       Impact factor: 6.725

7.  The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.

Authors:  A Inoue; M Yanagisawa; S Kimura; Y Kasuya; T Miyauchi; K Goto; T Masaki
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Cell-free synthesis of isotopically labelled peptide ligands for the functional characterization of G protein-coupled receptors.

Authors:  Lisa Joedicke; Raphael Trenker; Julian D Langer; Hartmut Michel; Julia Preu
Journal:  FEBS Open Bio       Date:  2015-12-29       Impact factor: 2.693

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.